Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Musca

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
La Clinica Terapeutica|August 15, 1982
[Effects of cod liver oil on platelet aggregation and lipid parameters]C Cordova, A Musca, F Violi, et al.
Hepato-Gastroenterology|October 1, 1984
Circulating HBsAg/IgM complexes in acute and chronic hepatitis BA Musca, C Cordova, V Barnaba, et al.
Scandinavian Journal of Gastroenterology|November 1, 2002
Liver fibrosis: what's the beginning of autonomic deficit?A Musca, V Paoletti, A De Matteis, et al.
Clinical and Experimental Immunology|August 1, 1983
Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infectionV Barnaba, A Musca, C Cordova, et al.
La Clinica Terapeutica|May 1, 1995
[Tolerability and side effects of interferon alpha in the treatment of chronic viral hepatitis]V Paoletti, G Galeotta, A Mammarella, et al.
Liver|February 1, 1986
Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH)V Barnaba, M Levrero, A Franco, et al.
La Clinica Terapeutica|July 31, 1983
[Behavior of the fibrinogen polymerization curve in patients with chronic respiratory insufficiency]A Musca, C Cordova, F Violi, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1979
Development of new antithrombogenic surfaces by employing platelet antiaggregating agents: preparation and characterizationW Marconi, F Bartoli, E Mantovani, et al.
Neuro Endocrinology Letters|May 4, 2001
Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid diseaseA Martocchia, G Labbadia, V Paoletti, et al.
Panminerva Medica|November 16, 2002
Prevalence and clinical features of skin diseases in chronic HCV infection. A prospective study in 96 patientsV Paoletti, A Mammarella, S Basili, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
La Clinica Terapeutica|August 15, 1982
[Effects of cod liver oil on platelet aggregation and lipid parameters]C Cordova, A Musca, F Violi, et al.
Hepato-Gastroenterology|October 1, 1984
Circulating HBsAg/IgM complexes in acute and chronic hepatitis BA Musca, C Cordova, V Barnaba, et al.
Scandinavian Journal of Gastroenterology|November 1, 2002
Liver fibrosis: what's the beginning of autonomic deficit?A Musca, V Paoletti, A De Matteis, et al.
Clinical and Experimental Immunology|August 1, 1983
Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infectionV Barnaba, A Musca, C Cordova, et al.
La Clinica Terapeutica|May 1, 1995
[Tolerability and side effects of interferon alpha in the treatment of chronic viral hepatitis]V Paoletti, G Galeotta, A Mammarella, et al.
Liver|February 1, 1986
Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH)V Barnaba, M Levrero, A Franco, et al.
La Clinica Terapeutica|July 31, 1983
[Behavior of the fibrinogen polymerization curve in patients with chronic respiratory insufficiency]A Musca, C Cordova, F Violi, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1979
Development of new antithrombogenic surfaces by employing platelet antiaggregating agents: preparation and characterizationW Marconi, F Bartoli, E Mantovani, et al.
Neuro Endocrinology Letters|May 4, 2001
Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid diseaseA Martocchia, G Labbadia, V Paoletti, et al.
Panminerva Medica|November 16, 2002
Prevalence and clinical features of skin diseases in chronic HCV infection. A prospective study in 96 patientsV Paoletti, A Mammarella, S Basili, et al.
Pageof 11